by David Sires | Jun 21, 2026 | Blog
Summary: “Why Are Liver Cancer Rates Rising in the U.S.?” (AARP) The video explains that liver cancer rates in the United States have tripled over the past 40 years, with a major driver being the rise in obesity and fatty liver disease. Historically, viral hepatitis...
by Pete Celano | Jun 19, 2026 | Blog
It’s very very low awareness today, Hepatology aka Liver Disease.Thus we started a free website aimed at the 4 Ps — Patients / Providers / Payers / Pharmas, called www.liverpilot.com. Join us here!
by Pete Celano | Jun 17, 2026 | Blog, Press
LiverRight Announces the Liververse™: Offering Referring Primary Care, GI and Endocrinology Practices Same-Week Telemedicine Appointment Access for Their Liver Patients For Providers with Liver Elastography (TE/SWE), an Additional Option of Same-Day Reads News...
by Pete Celano | Jun 15, 2026 | Blog
Per the article from FirstWorld Pharma titled “Nudge increases prescriptions of medication for drinking”, published June 9, 2026– A “nudging” strategy in the emergency department (ED) may be a path for prescribing a medication that can blunt cravings...
by Brandon Tudor | Jun 13, 2026 | Blog
Summary: Quality of Life Remains Stable in Autoimmune Liver Disease (EMJ Hepatology, June 2026) The article reports on a longitudinal study of 252 patients with autoimmune liver diseases (AILD)—including autoimmune hepatitis (AIH), primary biliary cholangitis (PBC),...
by David Sires | Jun 10, 2026 | Blog
The article titled “New study reveals turbocharged GLP-1 drug helps shed body weight and fat in the liver” delineates a VCU Health report on survodutide, a next-generation obesity/liver disease drug that combines GLP-1 agonism (similar to Ozempic/Wegovy)...
